Johnson & Johnson seeks nod for Covid vaccine trial on adolescents

To achieve herd immunity, studies have to be done on children, pharma major says

Johnson & Johnson
Premium

J&J already has the emergency use authorisation (EUA) for its single-shot vaccine in India.

Sohini Das Mumbai
US-based pharmaceutical major Johnson & Johnson (J&J) has sought permission from the Indian drug regulator to conduct trials of its Covid-19 vaccine on adolescents aged 12 to 17 years.
 
 The company said on Friday that it had submitted an application to the Central Drugs Standard Control Organisation (CDSCO) on August 17 in this regard. “Johnson & Johnson is committed to facilitating global equitable access to its Covid-19 vaccine and recognise the unmet needs of children,” the company spokesperson said.
 
The company said that to achieve herd immunity, vaccine trials have to be done on children. “To ultimately achieve

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 21 2021 | 1:54 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com